Trademark Overview
On Monday, September 22, 2025, a trademark application was filed for NEUROLENS with the United States Patent and Trademark Office. The USPTO has given the NEUROLENS trademark a serial number of 99405779. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, September 22, 2025. This trademark is owned by Resonant, LLC. The NEUROLENS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Blood testing kits comprised of medical diagnostic reagents and assays that test and track biomarkers of neurodegenerative diseases and neuron cell deaths; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of blood to detect and monitor neurodegenerative diseases and patient therapeutic responses; Reagents for use in cfDNA methylation sequencing for medical purposes; Diagnostic test reagents for medical purposes
Blood testing and analysis services for medical and clinical purposes; Medical laboratory testing and analysis services; Providing medical and health information on the detection, diagnosis, monitoring, and evaluation of neurological diseases, treatments, and patient therapeutic responses
Blood testing and analysis services for scientific research purposes; Medical research laboratory services; Providing scientific research information on the detection, diagnosis, monitoring, and evaluation of neurological diseases, treatments, and patient therapeutic responses